Javascript must be enabled to continue!
“Struck down by cancer with no old life to fall back on” a clinical study of illness experiences among Norwegian adolescent and young adult cancer survivors investigating the ethical implications of their illness narratives
View through CrossRef
AbstractBackgroundCancer is a leading cause of death among people 15–24 years of age. Increasing numbers of cancer patients survive. Extensive cancer therapy may cause wide‐ranging somatic and psychosocial challenges in the lives of the survivors.Research indicates adolescent and young adult cancer (AYA) survivors need to be seen as a distinctive group of survivors having unique health care needs. The existing literature suggests the need for specific follow‐up care programs addressing the challenges of AYAs and providing them access to specialized after care, as well as a need to explore AYA cancer survivors' own illness experiences.AimsThrough the theoretical lens of narrative medicine and care ethics, our purpose was to investigate the particular challenges encountered by the AYA cancer survivors, and how they view themselves in light of their illness experiences. We ask how AYA cancer survivors are met and understood by their medical professionals?MethodsThis study applied a qualitative method using a narrative research design by collecting self‐stories of illness in order to conceptualize human experiences of illness among AYA cancer survivors. Eight in‐depth interviews were conducted using a narrative analysis according to the narrative plots ofrestitution,chaosandquest,as suggested by Arthur Frank.ResultsHopelessness and a struggle to take part in the activities of daily life as survivors of cancer were revealed. Too ill to fully take part in the society, the AYA cancer survivors strive to be understood for what they are, namely young survivors.ConclusionThe survivors'stories reveal a moral imperative that needs to be honored by medical professionals in order to improve cancer care. Cancer survivorship may be a lifelong process necessitating long‐term follow‐up care. With the lack of specific care programs for AYA cancer survivors, follow‐up care is provided by general practitioners or other medical professionals, who often lack expertise in the unique challenges faced by AYA survivors. Because they feel their needs are unmet and their stories not understood, the AYA survivors might experience a sense of abandonment. By adopting a care ethics and narrative medicine approach we provide medical professionals a theoretical framework to better understand and care for AYA cancer survivors. Clinical trial number is 2012/1141.
Title: “Struck down by cancer with no old life to fall back on” a clinical study of illness experiences among Norwegian adolescent and young adult cancer survivors investigating the ethical implications of their illness narratives
Description:
AbstractBackgroundCancer is a leading cause of death among people 15–24 years of age.
Increasing numbers of cancer patients survive.
Extensive cancer therapy may cause wide‐ranging somatic and psychosocial challenges in the lives of the survivors.
Research indicates adolescent and young adult cancer (AYA) survivors need to be seen as a distinctive group of survivors having unique health care needs.
The existing literature suggests the need for specific follow‐up care programs addressing the challenges of AYAs and providing them access to specialized after care, as well as a need to explore AYA cancer survivors' own illness experiences.
AimsThrough the theoretical lens of narrative medicine and care ethics, our purpose was to investigate the particular challenges encountered by the AYA cancer survivors, and how they view themselves in light of their illness experiences.
We ask how AYA cancer survivors are met and understood by their medical professionals?MethodsThis study applied a qualitative method using a narrative research design by collecting self‐stories of illness in order to conceptualize human experiences of illness among AYA cancer survivors.
Eight in‐depth interviews were conducted using a narrative analysis according to the narrative plots ofrestitution,chaosandquest,as suggested by Arthur Frank.
ResultsHopelessness and a struggle to take part in the activities of daily life as survivors of cancer were revealed.
Too ill to fully take part in the society, the AYA cancer survivors strive to be understood for what they are, namely young survivors.
ConclusionThe survivors'stories reveal a moral imperative that needs to be honored by medical professionals in order to improve cancer care.
Cancer survivorship may be a lifelong process necessitating long‐term follow‐up care.
With the lack of specific care programs for AYA cancer survivors, follow‐up care is provided by general practitioners or other medical professionals, who often lack expertise in the unique challenges faced by AYA survivors.
Because they feel their needs are unmet and their stories not understood, the AYA survivors might experience a sense of abandonment.
By adopting a care ethics and narrative medicine approach we provide medical professionals a theoretical framework to better understand and care for AYA cancer survivors.
Clinical trial number is 2012/1141.
Related Results
Materialism and Environmental Knowledge as a Mediator for Relationships between Religiosity and Ethical Consumption
Materialism and Environmental Knowledge as a Mediator for Relationships between Religiosity and Ethical Consumption
ABSTRACTOn a global and regional scale, Indonesia has one of the least environmentally sustainable economies in the Asia-Pacific region. Consumption is one of the key factors contr...
Abstract B28: Catering to the needs of young and older Asian American breast cancer survivors: In-depth interviews
Abstract B28: Catering to the needs of young and older Asian American breast cancer survivors: In-depth interviews
Abstract
Objective: Breast cancer has been rapidly increasing in Asian American women in the United States. Breast cancer may have different physical and psychosocia...
Abnormal immunity of non-survivors with COVID-19: predictors for mortality
Abnormal immunity of non-survivors with COVID-19: predictors for mortality
Abstract
Background The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread all over the world. The specific information about immunity of non-survivors with...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Gender difference in vulnerability and geriatric syndromes among elderly cancer survivors.
Gender difference in vulnerability and geriatric syndromes among elderly cancer survivors.
9091 Background: Few studies have evaluated the gender difference of vulnerability and geriatric syndromes (GS) among cancer survivors. Methods: Using 2003 Medicare Current Benefi...
Sarcopenia and preserved bone mineral density in paediatric survivors of high‐risk neuroblastoma with growth failure
Sarcopenia and preserved bone mineral density in paediatric survivors of high‐risk neuroblastoma with growth failure
AbstractBackgroundSurvival from paediatric high‐risk neuroblastoma (HR‐NBL) has increased, but cis‐retinoic acid (cis‐RA), the cornerstone of HR‐NBL therapy, can cause osteoporosis...
Attitudes of Adolescent Cancer Survivors Toward End-of-Life Decisions for Minors
Attitudes of Adolescent Cancer Survivors Toward End-of-Life Decisions for Minors
OBJECTIVES: The present study aimed to investigate the attitudes of adolescent cancer survivors toward end-of-life decisions with life-shortening effects, including nontreatment de...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...


